It was occasionally observed that the TGF-β signalling mechanism might be impaired, and a significant decrease in pulmonary SMAD3 expression was detected in pulmonary hypertension animal models as well as in patients253–255, suggesting a decrease in the activity of the canonical TGF-β pathway242. This evidence concerns the gene TGFB1 and pulmonary hypertension.